Starpharma receives positive feedback from FDA on DEP® SN38 clinical pathway for platinum-resistant ovarian cancer
Posted: 19 December 2024 Starpharma (ASX: SPL, US OTC: SPHRY), an innovative biotechnology company with two decades of experience in advancing dendrimer technology from the lab to the patient, today announces a positive development regarding its DEP® SN38 (DEP®…
Stem Cells: Hope on the Horizon for Preterm Babies
Posted: 18 December 2024 Australian researchers have discovered a potential new lifeline for the tiniest and most vulnerable newborns. Scientists at Monash Children’s Hospital have successfully collected and reinfused umbilical cord blood cells in extremely premature babies, offering…
Cartherics awarded US$300K G-Rex Grant to accelerate clincial manufacturing of CAR-NK cell therapy
Posted: 18 December 2024 Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company focused on developing immune cell therapies for cancer and other diseases, is pleased to announce that it has been awarded a US$300K G-Rex grant to…
4DMedical wins contract to supply lung imaging technology to US radiology company
Posted: 17 December 2024 4DMedical (ASX: 4DX) has been awarded a contract with US-based Imaging Partners of Orange County (IPOC) to provide computed tomography (CT) scans for lung ventilation (LVAS) and lung density (LDAf) analysis. The contract – the…
Weaponising exosomes for breast cancer treatment
Posted: 17 December 2024 INOVIQ Limited (ASX:IIQ or INOVIQ) is pleased to announce that it has successfully completed stage 1 of its development program for an exosome therapeutic for breast cancer. In this in vitro proof-ofconcept (POC) study,…
Immutep Reports Promising New Data in Head and Neck Cancer at ESMO Immuno-Oncology 2024
Posted: 16 December 2024 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces positive clinical results from Cohort B of the TACTI-003…
Positive new data and strong recruitment in pancreatic cancer trial
Posted: 11 December 2024 Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to report updated data from Company’s ongoing Phase 2a clinical trial. This trial is investigating the Company’s FAK inhibitor narmafotinib in combination with…
Ghana becomes first river blindness-endemic country to approve moxidectin
Posted: 10 December 2024 Medicines Development for Global Health (MDGH) announced today that the Ghana Food and Drugs Authority (FDA) has approved the marketing authorisation application for moxidectin 2 mg oral tablets for the treatment of river blindness (onchocerciasis)…
University of Melbourne and Colossal expand partnership with gift to support avian conservation
Posted: 10 December 2024 A US$1.5 million gift from the Colossal Foundation, a non-profit organisation established by Colossal Biosciences, will help researchers in the Faculty of Science develop new approaches to the conservation of bird species in Australia and…
Breakthrough Victoria invests in game changing aged care technology
Posted: 10 December 2024 Breakthrough Victoria is investing $2 million in Umps Health, a Victorian company developing sensors and AI to enable proactive aged care at home. The Umps Link, a smart home platform, is the product of…
Australian researchers win the ‘Nobel’ of high-performance computing
Posted: 10 December 2024 An Australian research team and their American collaborators have been awarded the 2024 Gordon Bell Prize, regarded as the ‘Nobel Prize’ of high-performance computing (HPC). University of Melbourne Associate Professor Giuseppe Barca and his team were named the winners…
University of Melbourne and Peter MacCallum Cancer Centre leading genomics-driven cancer prevention
Posted: 10 December 2024 Genomics-driven cancer prevention, testing and treatment strategies will be at the forefront of a new joint venture between the University of Melbourne and Peter MacCallum Cancer Centre (Peter Mac), announced in Melbourne today. The…
